Email bulletins

To sign up for our monthly hepatitis news bulletins, please enter your details below.

Email

Repeat email

Country

Primary interest

Preferred language

Please note, this bulletin is in English.
When we report from The International Liver Congress (April) and The Liver Meeting (November), the bulletin is also available in French, Spanish, Portuguese and
Russian. If you would like to sign up to one of these translated bulletins, please choose your language from the list below.

To unsubscribe, please click here.

Archive

June 2020

International NASH Day
NASH is fastest-growing reason for a liver transplant in United States
Bacterial infection of the heart on the rise among people with hepatitis C in United States
Cameroon study shows hepatitis C treatment is feasible, highly effective in sub-Saharan Africa
Hepatitis C in England: deaths decline but new infections steady since 2011
World Hepatitis Day website and campaign materials launched
Is this your copy of the infohep news bulletin?

May 2020

COVID-19 in chronic liver disease: advanced cirrhosis greatly raises risk of death
Controversy: Does non-alcoholic fatty liver disease raise the risk of COVID-19?
Weight gain after hepatitis C cure is common
Short-course treatment for recent hepatitis C: some courses may be too short
Non-alcoholic fatty liver disease affects a quarter of lean people living with HIV
New estimates highlight need to step up the response to hepatitis D
International Liver Congress 2020 to take place online
Is this your copy of the infohep news bulletin?

April 2020

Liver transplants and COVID-19
Fatty liver disease may increase risk of severe COVID-19 disease
New resources on liver disease and COVID-19
Directly observed treatment for hepatitis C highly effective in people who inject drugs
Hepatitis C transmission in men who have sex with men
Is this your copy of the infohep news bulletin?

March 2020

Liver specialists offer guidance on COVID-19 risks in liver patients
Are people with chronic liver disease at higher risk of severe COVID-19 symptoms?
Advice on coronavirus (SARS-CoV-2 / COVID-19) for people with viral hepatitis or liver disease
All adults ages 18 to 79 should be screened for hepatitis C
London sets out route map for hepatitis C elimination
HIV-positive people with fatty liver disease are at high risk for fibrosis
EASL postpones International Liver Congress 2020 until August
Epclusa approved for children aged six and over in United States
Is this your copy of the infohep news bulletin?

February 2020

Hepatitis C treatment and prevention failing to reach people most affected
Increase in clean needle and syringe provision essential for hepatitis C elimination
Half of people who inject drugs in Middle East have hepatitis C
90% of injection drug users miss opportunities for HIV or HCV testing
Hepatitis B treatment suboptimal in people with HIV in Africa
Medicines Patent Pool and Mylan sign agreement to scale up access to first generic version of hepatitis C treatment glecaprevir/pibrentasvir
Is this your copy of the infohep news bulletin?

January 2020

London: hepatitis C elimination depends on testing scale-up
HepCheck screening programme links 80% to hepatitis C care in 4 European countries
Peer-led outreach improves uptake of hepatitis C care among homeless and people who use drugs
Hepatitis C screening among PrEP users could eliminate hepatitis C infections in gay men in UK
How to check drug interactions with hepatitis C drugs
Programme provides medical lockers for homeless people to store prescriptions
Hepatitis C-positive donors a viable option to expand heart donor pool
Egypt screens 1.6 million school students for hepatitis C
Is this your copy of the infohep news bulletin?